U.S. Advanced Therapy Medicinal Products Cdmo Market Size & Outlook
U.S. advanced therapy medicinal products cdmo market, 2018-2028 (US$M)
Related Markets
U.S. advanced therapy medicinal products cdmo market highlights
- The U.S. advanced therapy medicinal products cdmo market generated a revenue of USD 2,459.2 million in 2021 and is expected to reach USD 5,047.9 million by 2028.
- The U.S. market is expected to grow at a CAGR of 10.8% from 2022 to 2028.
- In terms of segment, gene therapy was the largest revenue generating product in 2021.
- Cell Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
Advanced therapy medicinal products cdmo market data book summary
| Market revenue in 2021 | USD 2,459.2 million |
| Market revenue in 2028 | USD 5,047.9 million |
| Growth rate | 10.8% (CAGR from 2021 to 2028) |
| Largest segment | Gene therapy |
| Fastest growing segment | Cell Therapy |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Therapy, Cell Therapy, Tissue Engineered, Others (Combined ATMPs, for example biodegradable matric or scaffold) |
| Key market players worldwide | AGC Inc, Catalent Inc, Lonza Group Ltd, Wuxi AppTec Co Ltd, Cencora Inc, Resonac Holdings Corp, Thermo Fisher Scientific Inc, CELONIC, Bio Elpida, CGT Catapult, Rentschler Biopharma SE |
Other key industry trends
- In terms of revenue, U.S. accounted for 42.1% of the global advanced therapy medicinal products cdmo market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. advanced therapy medicinal products cdmo market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 917.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Advanced Therapy Medicinal Products CDMO Market Scope
Advanced Therapy Medicinal Products CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. advanced therapy medicinal products cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to advanced therapy medicinal products cdmo market will help companies and investors design strategic landscapes.
Gene therapy was the largest segment with a revenue share of 53% in 2021. Horizon Databook has segmented the U.S. advanced therapy medicinal products cdmo market based on gene therapy, cell therapy, tissue engineered, others (combined atmps, for example biodegradable matric or scaffold) covering the revenue growth of each sub-segment from 2018 to 2028.
Reasons to subscribe to U.S. advanced therapy medicinal products cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. advanced therapy medicinal products cdmo market databook
-
Our clientele includes a mix of advanced therapy medicinal products cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. advanced therapy medicinal products cdmo market , including forecasts for subscribers. This country databook contains high-level insights into U.S. advanced therapy medicinal products cdmo market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. advanced therapy medicinal products cdmo market size, by product, 2018-2028 (US$M)
U.S. Advanced Therapy Medicinal Products CDMO Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
